Verified Panel · Burden Studies · Diagnostic Journey
A distinct burden profile that compounds over time
Rare pulmonary conditions impose a distinct burden profile centered on progressive breathlessness, oxygen dependency, and activity limitation that compounds over time — alongside frequent overlap with cardiac and broader systemic complications.
MedPanel applies verified panel recruitment and condition-specific methodology to research in this therapeutic area, supporting sponsors from early disease understanding through post-launch effectiveness research.
Functional decline · Equipment · Diagnostic delay
N. America · Europe · Asia-Pacific · LATAM
Physician attestation · Medical record
Confirmed rare diagnosis, not self-identification
Why This Therapeutic Area Requires Distinct Research Design
Three characteristics of rare pulmonary disease shape how research in this area must be designed, and each requires more than a generic respiratory instrument provides.
- Functional decline measurement. This is central to nearly every research objective in rare pulmonary disease, and capturing it accurately requires more granularity than general respiratory quality-of-life instruments typically provide. Activity limitation in rare pulmonary conditions often progresses in a stepwise rather than linear fashion, with patients adapting their daily routines around their current functional ceiling — adaptation that can mask true disease burden if research instruments do not specifically probe for it.
- Oxygen and equipment dependency. This introduces a logistical burden dimension that is specific to this therapeutic area and frequently underrepresented in standard burden frameworks — equipment maintenance, travel planning around oxygen access, and the practical and psychological impact of visible dependency on assistive equipment.
- Diagnostic overlap with common conditions. Overlap with more common respiratory and cardiac conditions means that patients in this category often experience significant diagnostic delay, with symptoms initially attributed to asthma, COPD, or other prevalent conditions before a rare pulmonary diagnosis is reached.
Research Approaches MedPanel Applies in This Therapeutic Area
MedPanel matches methodology to the specific research question, drawing on condition-specific burden, diagnostic-journey, caregiver, and treatment-pathway research designs.
Burden-of-illness research
Burden-of-illness research in rare pulmonary disease requires instruments sensitive to stepwise functional decline and equipment dependency burden specifically. MedPanel’s burden studies methodology incorporates condition-specific probing for these dimensions rather than relying on generic respiratory burden scales alone.
Diagnostic journey research
Diagnostic journey research captures the path to diagnosis and the experience of prior misdiagnosis, supporting both physician education strategy and patient awareness initiatives aimed at reducing time to accurate diagnosis. MedPanel’s in-depth interview methodology is well-suited to this narrative-rich research objective.
Caregiver research
Caregiver research is relevant for patients with significant functional limitation or oxygen dependency requiring substantial logistical support, and MedPanel’s caregiver studies practice extends to this population with appropriate burden framework adaptation.
Treatment and care pathway research
Treatment and care pathway research, including physician treatment selection rationale and patient experience with pulmonary rehabilitation, oxygen therapy, and emerging disease-modifying treatments, draws on MedPanel’s physician and KOL survey and focus group methodologies as appropriate to the specific research question.
A Verified Panel for a Diagnostically Nuanced Population
Prior misdiagnosis is common in rare pulmonary conditions, which makes recruitment verification central to sample quality.
Given the frequency of prior misdiagnosis in rare pulmonary conditions, recruitment verification is particularly important to ensure study samples reflect patients with confirmed rare diagnoses rather than individuals with overlapping common respiratory conditions who may self-identify imprecisely. MedPanel’s verification protocol — physician attestation and medical record confirmation — addresses this directly.
MedPanel’s global reach across North America, Europe, Asia-Pacific, and Latin America supports research across healthcare systems with differing access to specialist pulmonology care and diagnostic infrastructure, both of which materially affect time-to-diagnosis patterns relevant to many research programs in this category.
Start your research
Start Your Rare Pulmonary Condition Research Program
From functional decline burden assessment to diagnostic journey mapping, MedPanel’s verified panel and rare disease specialists bring methodological precision suited to this therapeutic area’s specific burden profile.
Panel feasibility confirmed for your target population
Methodology recommended for your study goals
Verified recruitment — physician attestation & medical record
Global reach across four regions
Contact MedPanel to discuss your research objectives in rare pulmonary conditions. We will confirm panel feasibility and recommend a methodology suited to your study goals.